Article
Cancer therapy–induced cardiac metabolic reprogramming: A new frontier in cardio-oncology
23 Aug 2025
Abstract excerpt
With the continuous advancement of cancer treatment technology, cardiotoxicity has gradually become a significant concern regarding the quality of life and long-term prognosis of cancer patients. This review systematically explores the mechanisms of cardiac metabolic reprogramming during cancer treatment, highlighting the impact of chemotherapy, targeted therapy, immunotherapy, and other drugs on the metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
